Evidence map›Paper›PMID 38241225›Full record

ArticlePloS one2024

The role of medicines and therapeutics committees structure in supporting optimal antibacterial use in hospitals in Uganda: A mixed method study.

Isaac Magulu Kimbowa, Moses Ocan, Jackson Mukonzo, Mary Nakafeero, Jaran Eriksen, Cecilia Stålsby Lundborg, Jasper Ogwal-Okeng, Celestino Obua, Joan Kalyango

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Isaac Magulu KimbowaDepartment of Pharmacology and Therapeutics, Makerere University College of Health Sciences, Kampala, Uganda.ORCID 0000-0003-2339-4535
Moses OcanDepartment of Pharmacology and Therapeutics, Makerere University College of Health Sciences, Kampala, Uganda.
Jackson MukonzoDepartment of Pharmacology and Therapeutics, Makerere University College of Health Sciences, Kampala, Uganda.
Mary NakafeeroSchool of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.
Jaran EriksenDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-1146-5615
Cecilia Stålsby LundborgDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Jasper Ogwal-OkengOffice of the Vice Chancellor, Lira University, Lira, Uganda.
Celestino ObuaOffice of the Vice Chancellor, Mbarara University of Science and Technology, Mbarara, Uganda.
Joan KalyangoDepartment of Pharmacy, Makerere University College of Health Sciences, Kampala, Uganda.
Makerere University · UGKarolinska Institutet · SELira Hospital · UGMbarara University of Science and Technology · UG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the roles of Medicines and therapeutic committees (MTCs) have been expanding, there is limited information on the role of their structure in optimal antibacterial use in hospitals, especially in low-and-middle-income countries. Our study explored the structure and role of MTC in supporting antibacterial use in regional referral, general hospitals and tertiary private not-for-profit (PNFP) hospitals in Uganda. We conducted an explanatory sequential mixed-method approach with triangulation to explore the structure and functional role of MTCs from August 2019 to February 2020 in hospitals in Uganda. Quantitative data was collected using an interviewer-administered questionnaire among chairpersons or secretaries of MTCs and was analysed using descriptive statistics. We conducted key informant interviews using an interview guide among long-term serving members of MTCs to collect qualitative data which triangulated the quantitative data. The study revealed that sixteen hospitals had successfully established MTCs with an average duration of the MTCs' existence of 5.6 (+2.7) years. The membership of the MTCs varied between 7 and 14, with a median value of 10, and the majority of members in MTCs were pharmacists (15 out of 16) and clinical specialists (13 out of 16). The most frequent subcommittees of the 16 hospitals MTC were supply chain (n = 14), antimicrobial stewardship (n = 13), and infection control (n = 12). Majority (14 out of 16) of the MTCs supported availability and access of antibacterial use by selecting and evaluating antibacterials agents for their formulary lists using established criteria. Additionally, 15 out 16 MTCs conducted antimicrobial stewardship activities to support optimal antimicrobial use. In our study, MTC membership and subcommittees were critical structural components that aided the selection and evaluation antibacterials on hospital formulary lists and they supported optimal antibacterial use through implementing various antimicrobial stewardship activities. There is a need for the Ministry of Health to conduct more training on operationalising MTCs structures in all hospitals.

Indexed as

HospitalsPharmacy and Therapeutics CommitteeAnti-Bacterial AgentsHumansPharmacistsUgandaAnti-Bacterial Agents

Identifiers

PMID38241225
PMCPMC10798471
OpenAlexW4391023732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.